⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3064075 | 1.00 | — | — | |
| SCHEMBL31506939 | 0.97 | ADH1B (0.43) | — | |
| SCHEMBL30256736 | 0.97 | ADH1B (0.36) | — | |
| SCHEMBL29473325 | 0.97 | ADH1B (0.36) | — | |
| SCHEMBL30438412 | 0.97 | ADH1B (0.36) | — | |
| SCHEMBL30610976 | 0.97 | ADH1B (0.36) | — | |
| SCHEMBL24198393 | 0.77 | — | — | |
| SCHEMBL16805979 | 0.77 | — | — | |
| SCHEMBL22753768 | 0.73 | ADH1B (0.32) | — | |
| SCHEMBL31522602 | 0.73 | TRPA1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024084390-A1 | COMPOUNDS FOR THE ACTIVATION OF AMPK | PFIZER INC. (US) | 2024-04-25 | — | — | WO | disclosed |
| US-11135275-B2 | Coagulation factor-targeting to TREM-like transcript 1 (TLT-1) on activated platelets | NOVO NORDISK HEALTHCARE AG (CH) | 2021-10-05 | — | — | US | disclosed |
| US-20190083587-A1 | Coagulation factor-targeting to TLT-1 on activated platelets | NOVO NORDISK AS (DK) | 2019-03-21 | — | — | US | disclosed |
| US-20170355708-A1 | POTASSIUM CHANNEL MODULATORS | CADENT THERAPEUTICS, INC. | 2017-12-14 | — | — | US | disclosed |
| US-20150352108-A1 | AMINO-PYRIMIDINE COMPOUNDS AS INHIBITORS OF TBK1 AND/OR IKK EPSILON | ALZHEIMER'S INSTITUTE OF AMERICA (US) | 2015-12-10 | — | — | US | disclosed |
| US-8975235-B2 | Lysophosphatidic acid receptor antagonists | INTERMUNE, INC. (US) | 2015-03-10 | — | — | US | disclosed |
| US-8932795-B2 | Resist composition, method of forming resist pattern, novel compound, and acid generator | TOKYO OHKA KOGYO CO., LTD. (JP) | 2015-01-13 | — | — | US | disclosed |
| US-8932795-B2 | Resist composition, method of forming resist pattern, novel compound, and acid generator | TOKYO OHKA KOGYO CO., LTD. (JP) | 2015-01-13 | — | — | US | disclosed |
| US-20130072449-A1 | LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS | INTERMUNE, INC. (US) | 2013-03-21 | — | — | US | disclosed |
| US-8299285-B2 | Compounds for imaging and therapy | ISIS INNOVATION LIMITED (GB) | 2012-10-30 | — | — | US | disclosed |
| US-20120238540-A1 | AMINO-PYRIMIDINE COMPOUNDS AS INHIBITORS OF IKK EPSILON AND/OR TBK1 | MYREXIS, INC. (US) | 2012-09-20 | — | — | US | disclosed |
| US-20120238540-A1 | AMINO-PYRIMIDINE COMPOUNDS AS INHIBITORS OF IKK EPSILON AND/OR TBK1 | MYREXIS, INC. (US) | 2012-09-20 | — | — | US | disclosed |
| US-20110287362-A1 | RESIST COMPOSITION, METHOD OF FORMING RESIST PATTERN, NOVEL COMPOUND, AND ACID GENERATOR | TOKYO OHKA KOGYO CO., LTD. (JP) | 2011-11-24 | — | — | US | disclosed |
| US-20110287362-A1 | RESIST COMPOSITION, METHOD OF FORMING RESIST PATTERN, NOVEL COMPOUND, AND ACID GENERATOR | TOKYO OHKA KOGYO CO., LTD. (JP) | 2011-11-24 | — | — | US | disclosed |
| US-20110098353-A1 | Compounds for Imaging and Therapy | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2011-04-28 | — | — | US | disclosed |